Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tilson

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Medical Interface|February 7, 1996
Implications for managed care organizations of the Merck and Medco consentM R Pollard, H H Tilson
Pharmacoepidemiology and Drug Safety|October 11, 2021
For consideration by pharmacoepidemiologistsStanley A Edlavitch, Hugh H Tilson
American Journal of Preventive Medicine|September 25, 2001
Public health physicians: an endangered speciesH H Tilson, K M Gebbie
Life Sciences|October 3, 1983
Long-term effects of behavioral testing on serum hormones and brain weightL Uphouse, H Tilson, C L Mitchell
Health Affairs (Project Hope)|November 22, 2002
The public health workforceKristine Gebbie, Jacqueline Merrill, Hugh H Tilson
Pharmacoepidemiology and Drug Safety|September 27, 2005
Defining the competencies of those conducting pharmacovigilanceBrian Edwards, Hugh H Tilson, Suzanne L West
Life Sciences|January 1, 1991
Age-related changes in receptor-mediated phosphoinositide hydrolysis in various regions of rat brainW Mundy, P Tandon, S Ali, et al.
Journal of Oral Surgery (American Dental Association : 1965)|October 1, 1976
Clinicopathological conference. Case 17, part 2. Juvenile ossifying fibromaD Test, C Schow, D Cohen, et al.
Environmental Health Perspectives|April 1, 1996
Risk assessment for neurobehavioral toxicity: SGOMSEC joint reportD Hattis, J Glowa, H Tilson, et al.
Infection Control and Hospital Epidemiology|June 1, 1989
Expanding roles of hospital epidemiology: pharmacoepidemiologyJ P Burke, H H Tilson, R Platt
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Medical Interface|February 7, 1996
Implications for managed care organizations of the Merck and Medco consentM R Pollard, H H Tilson
Pharmacoepidemiology and Drug Safety|October 11, 2021
For consideration by pharmacoepidemiologistsStanley A Edlavitch, Hugh H Tilson
American Journal of Preventive Medicine|September 25, 2001
Public health physicians: an endangered speciesH H Tilson, K M Gebbie
Life Sciences|October 3, 1983
Long-term effects of behavioral testing on serum hormones and brain weightL Uphouse, H Tilson, C L Mitchell
Health Affairs (Project Hope)|November 22, 2002
The public health workforceKristine Gebbie, Jacqueline Merrill, Hugh H Tilson
Pharmacoepidemiology and Drug Safety|September 27, 2005
Defining the competencies of those conducting pharmacovigilanceBrian Edwards, Hugh H Tilson, Suzanne L West
Life Sciences|January 1, 1991
Age-related changes in receptor-mediated phosphoinositide hydrolysis in various regions of rat brainW Mundy, P Tandon, S Ali, et al.
Journal of Oral Surgery (American Dental Association : 1965)|October 1, 1976
Clinicopathological conference. Case 17, part 2. Juvenile ossifying fibromaD Test, C Schow, D Cohen, et al.
Environmental Health Perspectives|April 1, 1996
Risk assessment for neurobehavioral toxicity: SGOMSEC joint reportD Hattis, J Glowa, H Tilson, et al.
Infection Control and Hospital Epidemiology|June 1, 1989
Expanding roles of hospital epidemiology: pharmacoepidemiologyJ P Burke, H H Tilson, R Platt
Pageof 10